Cabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs. [electronic resource]

By: Contributor(s): Producer: 20190530Description: 847-849 p. digitalISSN:
  • 1555-8576
Subject(s): Online resources: In: Cancer biology & therapy vol. 19
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Letter; Comment

There are no comments on this title.

to post a comment.